Literature DB >> 32150624

Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies.

Markus Brüll1, Anna-Sophie Spreng1,2, Simon Gutbier3, Dominik Loser4, Alice Krebs1,2, Marvin Reich1,3, Udo Kraushaar4, Markus Britschgi3, Christoph Patsch3, Marcel Leist1,2.   

Abstract

Human cell-based neural organoids are increasingly being used for investigations of neurotoxicity, and to study the pathophysiology of neurodegenerative diseases. Here, we present a fast and robust method to generate 3D cultured human dopaminergic neurons (LUHMES) for toxicity testing and long-term culture. Moreover, a plating step was introduced to allow generation of neurite networks with defined 2D orientation and several mm length, while all cell bodies (somata) remained in a 3D, dome-like structure. These cultures, named here 2.5D (for 2.5 dimensional), offer new approaches to quantify toxicant effects on organoids by standard technology and high throughput. For instance, the system reacted to the parkinsonian model toxicants MPP+, rotenone, MG-132 and the ferroptosis-inducer erastin. Moreover, stable incorporation of human stem cell-derived astrocytes or microglia was possible. Added astrocytes stabilized the post mitotic state of the LUHMES neurons and thereby allowed the formation of a stable micro-physiological system. We observed neuroprotection against the proteasome inhibitor MG-132 and the ferroptosis-inducer erastin by such glia. This exemplifies the crucial protective role of astrocytes in neurodegeneration. The modularity of the system was further employed to incorporate microglia together with astrocytes into the organoids. Such ratio-defined, three cell type-based organoids will allow new approaches to study human pathophysiology and toxicology of the nervous system.

Entities:  

Keywords:  3D LUHMES; Parkinson’s disease; co-culture; microglia; neurite outgrowth; neurodegeneration; neuroprotection

Mesh:

Year:  2020        PMID: 32150624     DOI: 10.14573/altex.1911111

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  12 in total

1.  LUHMES Dopaminergic Neurons Are Uniquely Susceptible to Ferroptosis.

Authors:  Zhi-Bin Tong; Hyunhee Kim; Lara El Touny; Anton Simeonov; David Gerhold
Journal:  Neurotox Res       Date:  2022-08-04       Impact factor: 3.978

2.  Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening.

Authors:  Simon Gutbier; Florian Wanke; Nadine Dahm; Anna Rümmelin; Silke Zimmermann; Klaus Christensen; Fabian Köchl; Anna Rautanen; Klas Hatje; Barbara Geering; Jitao David Zhang; Markus Britschgi; Sally A Cowley; Christoph Patsch
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

3.  Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres are Suitable for Neurotoxicity Screening.

Authors:  Julianna Kobolak; Annamaria Teglasi; Tamas Bellak; Zofia Janstova; Kinga Molnar; Melinda Zana; Istvan Bock; Lajos Laszlo; Andras Dinnyes
Journal:  Cells       Date:  2020-05-01       Impact factor: 6.600

4.  Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.

Authors:  M J Moné; G Pallocca; S E Escher; T Exner; M Herzler; S Hougaard Bennekou; H Kamp; E D Kroese; Marcel Leist; T Steger-Hartmann; B van de Water
Journal:  Arch Toxicol       Date:  2020-09-04       Impact factor: 5.153

5.  Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors.

Authors:  Johannes Delp; Andrea Cediel-Ulloa; Ilinca Suciu; Petra Kranaster; Barbara Ma van Vugt-Lussenburg; Vesna Munic Kos; Wanda van der Stel; Giada Carta; Susanne Hougaard Bennekou; Paul Jennings; Bob van de Water; Anna Forsby; Marcel Leist
Journal:  Arch Toxicol       Date:  2021-01-29       Impact factor: 5.153

6.  Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling.

Authors:  Udo Kraushaar; Marcel Leist; Dominik Loser; Karin Grillberger; Maria G Hinojosa; Jonathan Blum; Yves Haufe; Timm Danker; Ylva Johansson; Clemens Möller; Annette Nicke; Susanne H Bennekou; Iain Gardner; Caroline Bauch; Paul Walker; Anna Forsby; Gerhard F Ecker
Journal:  Arch Toxicol       Date:  2021-10-10       Impact factor: 5.153

7.  Distinct and Dynamic Transcriptome Adaptations of iPSC-Generated Astrocytes after Cytokine Stimulation.

Authors:  Anna-Sophie Spreng; Markus Brüll; Heidrun Leisner; Ilinca Suciu; Marcel Leist
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

Review 8.  Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.

Authors:  Lalitha Venkataraman; Summer R Fair; Craig A McElroy; Mark E Hester; Hongjun Fu
Journal:  Stem Cell Rev Rep       Date:  2020-11-12       Impact factor: 6.692

Review 9.  Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.

Authors:  Georgia Kouroupi; Nasia Antoniou; Kanella Prodromidou; Era Taoufik; Rebecca Matsas
Journal:  Int J Mol Sci       Date:  2020-09-26       Impact factor: 5.923

10.  Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.

Authors:  Marvin Reich; Iñaki Paris; Martin Ebeling; Nadine Dahm; Christophe Schweitzer; Dieter Reinhardt; Roland Schmucki; Megana Prasad; Fabian Köchl; Marcel Leist; Sally A Cowley; Jitao David Zhang; Christoph Patsch; Simon Gutbier; Markus Britschgi
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.